Clinical trial

A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients

NCT00819637

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE4

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2023-05-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Asthmaunresolved

Interventions

arformoterol (RR formoterol)DRUG

placeboDRUG

levalbuterolDRUG · verified · RxNorm: levalbuterol

Sponsors & collaborators

Henry Ford Health Systemlead sponsor

Sumitomo Pharma America, Inc.collaborator

Mapped research locations

DetroitMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00819637 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.